Hepatic hydrothorax is a specific complication of decompensated liver cirrhosis defined by the accumulation of pleural transudate in the absence of primary cardiopulmonary or pleural disease. Its management requires a protocol tailored to the underlying liver condition and the patient's clinical status.
When hepatic hydrothorax becomes refractory and certain interventions are not feasible options, a pleural-directed procedure may be considered for carefully selected patients. Patient selection for this approach is critical due to the risk of associated side effects.
The complete protocol — covering full eligibility criteria, procedural considerations, contraindications, and clinical sequencing — is available below.
DOI: 10.1016/j.jhep.2018.03.024
Hepatic hydrotorax describes the accumulation of transudate in the pleural space of patients with decompensated cirrhosis in the absence of cardiac, pulmonary or pleural disease.
Pleurodesis can be suggested to patients with refractory hepatic hydrothorax not amenable to LT or TIPS insertion. However, the frequent occurrence of side effects related to this technique restricts its use to selected patients (I;2).
View source ↗